Roche Holding AG (LON:0QQ6)
303.40
+4.40 (1.47%)
At close: Oct 3, 2025
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
564.35K GBP
Profits / Employee
83.82K GBP
Market Cap
229.73B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103,249 | -356 | -0.34% |
Dec 31, 2023 | 103,605 | -8 | -0.01% |
Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
Dec 31, 2021 | 100,920 | -545 | -0.54% |
Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Roche Holding AG News
- 2 days ago - FDA Approves Roche's Tecentriq for Lung Cancer Treatment - GuruFocus
- 2 days ago - Roche's Genentech gets FDA nod for lung cancer treatment - Seeking Alpha
- 2 days ago - FDA approves Roche's Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer - GlobeNewsWire
- 2 days ago - Change in the Roche Board of Directors - GlobeNewsWire
- 3 days ago - FDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer - Business Wire
- 3 days ago - Roche Launches Tender Offer To Acquire 89bio For $14.50/shr Plus CVR - Nasdaq
- 4 days ago - Trade treaty kicks in, Swiss govt seeks investment pact - The Times of India
- 4 days ago - Roche Initiates Tender Offer for 89bio (ETNB) in $3.5B Acquisition - GuruFocus